Menarini, 150 mln for new factory in Italy

The Menarini group will build a new 40,000 square meter production center in Sesto Fiorentino, in the former Longinotti area. It is an investment of 150 million euros for over 250 jobs and as many in related industries.
    A protocol of understanding between the Region, the Municipality, the Metropolitan City and the company has been approved. "The project assumes strategic importance both for the recovery of an industrial area that has been standing still for some time, both for the type of activity and innovation, and for the employment effects and opportunities for Tuscan SMEs", comments the President of the Region, Enrico Rossi. 

The Menarini Group's turnover grew by 3.2% in 2019. The Group, which belongs to the Aleotti family but is guided by a governance that sees Enric Cornut in the chair and a woman, Elcin Barker Ergun, as CEO , has recently announced the purchase offer on the US biotech Stemline. Menarini closed 2019 with a turnover that touches 3.8 billion euros (3,793 million), an increase of 3.2% compared to 2018, and the ebitda is 492 million. Growth was driven by international markets despite the patent expiration of Adenuric (febuxostat), a drug for hyperuricemia. "The year that ended - commented President Eric Cornut - was obviously not affected by the Covid crisis, and saw Menarini increase its presence abroad and strengthen governance with the appointment of the Group CEO, Elcin Barker Ergun. Today international turnover is 77% of the total thanks to the dedication and commitment of our employees who - he concluded - bring the quality of Menarini drugs to the world ".